reference/35937730

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/35937730

Outgoing Links

Predicate	Object
contentType	Journal Article
issn	0920-1211
pageRange	107168-
publicationName	Epilepsy Research
startingPage	107168
bibliographicCitation	Chauhan A, Singh J, Sangwan N, Singh H, Prakash A, Medhi B, Avti PK. Designing the 5HT2BR structure and its modulation as a therapeutic target for repurposing approach in drug-resistant epilepsy. Epilepsy Res. 2023 Aug;194():107168. doi: 10.1016/j.eplepsyres.2023.107168. PMID: 37302343.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5f496b61a7eb2def67bbb6593f835277 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8dd6642a44b148928df8ecb4480cfe88 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5cb99203c2c916ee8543f692bfcdd315 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_186e2c1c38fb53cfd12b2ccc15199c6c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d4957760fa446b7f1785e231047360a3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_35cf25b8f0825ce9a441315410a45983 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3b5fd6e6b3175d84dab7352ea4df0530
date	202308
identifier	https://pubmed.ncbi.nlm.nih.gov/37302343 https://doi.org/10.1016/j.eplepsyres.2023.107168
isPartOf	https://portal.issn.org/resource/ISSN/0920-1211 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3587
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Designing the 5HT2BR structure and its modulation as a therapeutic target for repurposing approach in drug-resistant epilepsy
discusses	http://id.nlm.nih.gov/mesh/M0013636 http://id.nlm.nih.gov/mesh/M0136060
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D004827 http://id.nlm.nih.gov/mesh/D008755
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D056004 http://id.nlm.nih.gov/mesh/D000077465 http://id.nlm.nih.gov/mesh/D058492
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9191 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7621 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9681 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6522 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54746 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8226 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8223 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11431

Total number of triples: 38.